Records containing: Ovarian Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-06-05ANG-003 EMBER Study: Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass.
-
CLINICAL_TRIALS study record update · 2023-05-24Collection of Blood From Patients With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
-
CLINICAL_TRIALS study record update · 2023-04-25A Multicenter, Prospective, Randomized Trial Comparing Paclitaxel and Carboplatin or Bleomycin, Etoposide and Cisplatin in the Treatment of Ovarian Malignant Sex Cord-Stromal Tumors
-
CLINICAL_TRIALS study record update · 2023-04-25A Multicenter, Prospective, Randomized Trial Comparing Paclitaxel and Carboplatin or Bleomycin, Etoposide and Cisplatin in the Treatment of Malignant Ovarian Germ Cell Tumors
-
CLINICAL_TRIALS study record update · 2023-04-20Phase 1b, Multicentre, Multiple Ascending Dose, Safety, Pharmacokinetic, and Pharmacodynamic Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-03-23Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology
-
CLINICAL_TRIALS study record update · 2023-03-23Establishment of a Blood Sample Bank in the Field of Gynaecological Oncology.
-
CLINICAL_TRIALS study record update · 2023-03-15Role of Multi Paramertic MRI and MRI Perfusion in Indetermint Ovarian Lesions by Using ORADS MRI
-
CLINICAL_TRIALS study record update · 2023-03-14A Phase II Study of the Anti-PDL1 Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid to Investigate Safety and Efficacy of This Combination in Recurrent Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2023-03-02Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors
-
CLINICAL_TRIALS study record update · 2023-02-21Real-world Data From a Multi-center Study: Insights to the Effectiveness and Safety in Patients With Ovarian Cancer Receiving Niraparib as First-line Maintenance Therapy
-
CLINICAL_TRIALS study record update · 2022-09-27Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms.
-
CLINICAL_TRIALS study record update · 2022-09-10A Phase 2 Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients With Platinum-Resistant Ovarian Cancer (MOONSTONE)
-
CLINICAL_TRIALS study record update · 2022-07-20A Prospective Randomised Phase III Trial to Evaluate Optimal Treatment Duration of First-line Bevacizumab in Combination With Carboplatin and Paclitaxel in Patients With Primary Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2022-07-01Outcomes of First-line Olaparib Combined With Bevacizumab Maintenance Therapy in Newly Diagnosed Ovarian Cancer Patients With tBRCA Wild-type Tumors: a Real-world Study
-
CLINICAL_TRIALS study record update · 2022-06-13An Open-Label, Single-Arm Phase 2 Clinical Trial Of Regorafenib in Patients With Multiply Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2022-05-17Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2022-05-04A Randomized, Open-label, Three-arm, Multi-center Phase II Trial of Addition of DCVAC/OvCa to First Line Standard Chemotherapy in Women With Newly Diagnosed Epithelial Ovarian Carcinoma
-
CLINICAL_TRIALS study record update · 2022-04-12A Phase I/II Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor in Small Cell Cancers
-
CLINICAL_TRIALS study record update · 2022-02-17Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2022-02-17Treatment of Functional Ovarian Cyst Randomised Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-02-16A Retrospective Study of Brachytherapy in Gynecological Cancers
-
CLINICAL_TRIALS study record update · 2022-01-19A Phase 2, Single-arm, Open-label Study to Evaluate the Safety and Efficacy of Niraparib Combined With Bevacizumab as Maintenance Treatment in Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Following Front-line Platinum-based Chemotherapy With Bevacizumab
-
CLINICAL_TRIALS study record update · 2021-12-10Outcomes of First-line Olaparib Mono-maintenance Therapy in Newly Diagnosed Ovarian Cancer Patients With tBRCA Wild-type Tumors: a Realworld Study
-
CLINICAL_TRIALS study record update · 2021-10-26Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients